{
    "clinical_study": {
        "@rank": "43707", 
        "arm_group": [
            {
                "arm_group_label": "Test", 
                "arm_group_type": "Experimental", 
                "description": "Fibre rich Health Food Drink packed as 30g individual sachet, administered as a single serve in 200 mL of luke warm water"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "No Fibre Health Food Drink packed as 25g individual sachet, administered as single serve in 200 mL of luke warm water"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary aim of this study is to evaluate the effect of a fibre rich health food drink on\n      the post prandial glucose and triglyceride peak in healthy overweight adults with impaired\n      fasting glucose (IFG). The study is randomised, stratified, double blind, two treatments,\n      two period cross over study."
        }, 
        "brief_title": "The Effect of a Nutritional Supplement on Post Prandial Glucose and Lipids in an Adult Population", 
        "condition": "Impaired Fasting Glucose", 
        "condition_browse": {
            "mesh_term": "Prediabetic State"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy overweight male and female participants\n\n          -  Age 18-75 years\n\n          -  BMI \u226525<35 Kg/m2\n\n        Exclusion Criteria:\n\n          -  Pregnancy/breast-feeding\n\n          -  Allergy/Intolerance\n\n          -  Anaemic participants: Hb <10g/dL\n\n          -  Diabetic participants: fasting blood glucose >125 mg/dL\n\n          -  Serum Aspartate Transaminase, Alkaline Phosphatase and Serum albumin level 3 times\n             the upper limit of normal range\n\n          -  Participants on other medications (lipid lowering drugs, oral hypoglycemics)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "96", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02119325", 
            "org_study_id": "RH01899"
        }, 
        "intervention": [
            {
                "arm_group_label": "Test", 
                "description": "Test is a powdered beverage with an active component of 25% of fibre (resistant maltodextrin)", 
                "intervention_name": "25% fibre", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo is an energy matched powdered beverage", 
                "intervention_name": "0% fibre", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "fibre", 
            "impaired fasting glucose", 
            "overweight"
        ], 
        "lastchanged_date": "April 17, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ahmedabad", 
                    "country": "India", 
                    "state": "Gujarat", 
                    "zip": "380 061"
                }, 
                "name": "Lambda Therapeutic Research Ltd"
            }
        }, 
        "location_countries": {
            "country": "India"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of a Nutritional Supplement on Post Prandial Glucose and Lipids in an Adult Population", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "India:  Independent Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "To evaluate the effect of fibre rich health food drink on post prandial glucose peak in healthy overweight adults with impaired fasting glucose", 
                "measure": "Post prandial glucose peak", 
                "safety_issue": "No", 
                "time_frame": "Blood samples will be taken at fasting, 10, 20, 30, 40, 50 60, 75 90,105, 120,150,180,210 &amp; 240 minutes"
            }, 
            {
                "description": "To evaluate the effect of fibre rich health food drink on post prandial triglyceride peak in healthy overweight adults with impaired fasting glucose", 
                "measure": "Post prandial triglyceride peak", 
                "safety_issue": "No", 
                "time_frame": "Blood samples will be taken at fasting, 10, 20, 30, 40, 50 60, 75 90,105, 120,150,180,210 &amp; 240 minutes"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02119325"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "To evaluate the effect of fibre rich health food drink on post prandial glucose peak in healthy overweight adults", 
                "measure": "Post prandial glucose peak", 
                "safety_issue": "No", 
                "time_frame": "Blood samples will be taken at fasting, 10, 20, 30, 40, 50 60, 75 90,105, 120,150,180,210 &amp; 240 minutes"
            }, 
            {
                "description": "To evaluate the effect of fibre rich health food drink on post prandial triglyceride peak in healthy overweight adults", 
                "measure": "Post prandial triglyceride peak", 
                "safety_issue": "No", 
                "time_frame": "Blood samples will be taken at fasting, 10, 20, 30, 40, 50 60, 75 90,105, 120,150,180,210 &amp; 240 minutes"
            }, 
            {
                "description": "To evaluate the effects of a fibre rich health food drink on post prandial RLP-Cholesterol peak and insulin in healthy overweight adults with and without impaired fasting glucose", 
                "measure": "Post prandial Remnant Lipoprotein Cholesterol (RLP-Cholesterol) peak and insulin", 
                "safety_issue": "No", 
                "time_frame": "Blood samples will be taken at fasting, 10, 20, 30, 40, 50 60, 75 90,105, 120,150,180,210 &amp; 240 minutes"
            }, 
            {
                "description": "To estimate the effect of a fibre rich health food drink on the extent of the postprandial changes in serum triglycerides, blood glucose, RLP-Cholesterol and insulin by calculating the incremental area under the curve (IUAC)", 
                "measure": "Post prandial changes in serum triglycerides, blood glucose, RLP-Cholesterol and insulin", 
                "safety_issue": "No", 
                "time_frame": "Blood samples will be taken at fasting, 10, 20, 30, 40, 50 60, 75 90,105, 120,150,180,210 &amp; 240 minutes"
            }, 
            {
                "description": "To estimate the effect of a fibre rich health food drink on the time when the maximum post prandial concentration of blood glucose, serum triglycerides and serum RLP-Cholesterol is reached (Tmax)", 
                "measure": "Tmax for glucose, triglycerides and serum RLP-Cholesterol", 
                "safety_issue": "No", 
                "time_frame": "Blood samples will be taken at fasting, 10, 20, 30, 40, 50 60, 75 90,105, 120,150,180,210 &amp; 240 minutes"
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}